Using a co-culture in vitro model, we assessed the cytotoxic effect of CTLs on sunitinib-resistant and naïve ccRCC cell lines following treatment with 3 anti-PD-L1 blocking therapeutic antibodies (avelumab, atezolizumab, durvalumab). This evidence concerns the gene CD274 and nonpapillary renal cell carcinoma.